Teva settles shareholder lawsuit over generic drug | Business Insurance
Teva enters opioid settlement agreement with US state Rhode Island
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
On notice: Teva's entire $330m legal spend could go to one law firm – GC Magazine
UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT IN RE TEVA SECURITIES LITIGATION : No. 3:17-cv-00558 (SRU) LONG-FORM NO
Teva, Allergan Settle Opioid Lawsuit With West Virginia
Purdue Pharma, others could deduct opioid settlements from taxes
Irbesartan, Losartan and Valsartan (Azido Impurity) Class Action - Rice Harbut Elliott
Does Teva's $15M, 18-year opioid settlement with Louisiana signal the start of a trend? | Fierce Pharma
Teva charged in US price-fixing investigation | Financial Times
1 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF FLORIDA CASE NO.: MSP RECOVERY CLAIMS, SERIES LLC,
UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT ONTARIO TEACHERS' PENSION PLAN BOARD, Individually and as Lead Plaintiff
Kasowitz Benson Torres LLP | Kasowitz, on behalf of Teva, Resolves one of the Nation's Largest Securities Class Actions | Kasowitz Benson Torres LLP
Teva's U.S. Unit Charged in Generic-Drug Price-Fixing Probe - BNN Bloomberg
$24M Class Action Settlement Reached with Teva Over Nexium Pay-for-Delay - Top Class Actions
TEVA PHARMACEUTICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teva
Teva Pharmaceutical Industries Settles $420 Million Shareholder Lawsuit
Is 2019 The Trough For Teva, Or Will 2020 Continue To See Pressure? (NYSE: TEVA) | Seeking Alpha
Teva Class Action Claims Company Suppressed Competition For Generic Version Of MS Drug Copaxone - Top Class Actions
Teva Pharmaceuticals Retirement Savings Plan $2.55M Class Action Settlement - Top Class Actions
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Teva Settles Price-Fixing-Related Securities Class Action Litigation for $420 Million | The D&O Diary
Teva Shareholder Notice
